E-cigarettes for Harm Reduction in Adults With Asthma
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- Brown University
- Study ID
- NCT05278065
- Status
- Completed
Conditions
- Asthma
- Cigarette Smoking
- Electronic Cigarette Use
- Smoking
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Nicotine — OTHERParticipants will be provided with electronic cigarettes and 5% nicotine e-liquid cartridges for 8 weeks and encouraged at weekly assessments to use the electronic cigarette any time they would normally smoke. Participants will be able to choose commercially available e-liquid flavors (tobacco) at each weekly assessment.
Study Details
Smoking is the main cause of preventable disease and death in the US and impacts respiratory illnesses including COPD and asthma. However, little is known about the effects on smoking and lung health of substituting cigarettes with ENDS in adults with asthma. This project aims to test whether providing ENDS to adults with asthma will lead to substitution of smoking for ENDS, reduced dependence, and improved lung function so such knowledge can inform interventions to reduce the public health burden of tobacco.
Key Dates
- Start date
- May 1, 2022
- Status verified
- Nov 2025
- Primary completion
- Sep 12, 2024
- Completion
- Sep 12, 2024
Study Design
- Enrollment
- 17 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Electronic cigaretteParticipants in this experimental condition will be provided with a 4th generation electronic cigarette device and disposable cartridges.
- No Intervention: Smoking As UsualParticipants in this assessment-only condition will continue smoking as usual.
Primary Outcome Measure
Change in Cigarettes Per Day From Baseline to Week 8 and Week 16 [ Time Frame: Baseline, Week 8, Week 16 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center for Alcohol and Addiction Studies | Providence | Rhode Island | 02903 | - |
Find similar trials in Providence, RI
By condition
By specialty
By research site
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Personalized Environment and Genes StudyRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Chapel Hill, North Carolina
- Mechanism(s)of Airflow Limitation in Moderate-severe Persistent AsthmaRecruiting · Gelb, Arthur F., M.D. · Lakewood, California
- Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway InflammationPHASE1 · Recruiting · Benjamin Medoff · Boston, Massachusetts